KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $5.4 billion.

  • Eli Lilly's Accounts Payables rose 6658.41% to $5.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.4 billion, marking a year-over-year increase of 6658.41%. This contributed to the annual value of $5.4 billion for FY2025, which is 6658.41% up from last year.
  • Latest data reveals that Eli Lilly reported Accounts Payables of $5.4 billion as of Q4 2025, which was up 6658.41% from $4.3 billion recorded in Q3 2025.
  • Eli Lilly's 5-year Accounts Payables high stood at $5.4 billion for Q4 2025, and its period low was $1.4 billion during Q1 2022.
  • In the last 5 years, Eli Lilly's Accounts Payables had a median value of $2.5 billion in 2023 and averaged $2.6 billion.
  • Per our database at Business Quant, Eli Lilly's Accounts Payables crashed by 1258.23% in 2022 and then soared by 6658.41% in 2025.
  • Eli Lilly's Accounts Payables (Quarter) stood at $1.7 billion in 2021, then rose by 15.56% to $1.9 billion in 2022, then surged by 34.61% to $2.6 billion in 2023, then rose by 24.25% to $3.2 billion in 2024, then skyrocketed by 66.58% to $5.4 billion in 2025.
  • Its Accounts Payables stands at $5.4 billion for Q4 2025, versus $4.3 billion for Q3 2025 and $4.1 billion for Q2 2025.